Sterling Capital Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-74	Closed	-$90	–	3308
2025 Q1	$90	Buy	74 +36	+95%	+$44	﹤0.01%	3152
2024 Q4	$49	Hold	38	–	–	﹤0.01%	3213
2024 Q3	$105	Buy	+38	New	+$105	﹤0.01%	3189